The anti-parasitic drug became a household name during the COVID-19 pandemic, and it is now being embraced as an alternative ...
ZME Science on MSN
A new type of immunotherapy drug for prostate cancer shows up to 99% drop in cancer biomarkers
Our immune system is great at fighting many types of cancer, but it struggles to see prostate tumors. While new treatments ...
9d
Science for living: Can using AI risk prediction in breast cancer screening improve early detection?
Artificial intelligence is transforming medicine, but what does that mean for breast cancer screening? Researchers at UMass Chan Medical School are exploring how an AI-based tool might help identify ...
With up to $25 million from Cancer Grand Challenges, an international team led by UC San Diego professor Ludmil Alexandrov, ...
Researchers at the Cancer Research Institute and the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have uncovered a critical mechanism that enables gastric cancer to spread to ...
This month, the Department of Health and Human Services terminated almost $500 million in mRNA vaccine development grants and contracts. While HHS has said that these cuts won’t affect mRNA cancer ...
Biomolecular condensates were long believed to be simple liquid blobs inside cells. Researchers have now uncovered that some are actually supported by fine protein filaments forming an internal ...
Cancer cell-derived small extracellular vesicles (sEVs) can travel from distant tumors through the bloodstream and kidneys ...
Toni English’s medical team was giddy. It was six weeks after English had completed an experimental cancer treatment, and she had arrived at the Orlando Health Cancer Institute in Florida with her ...
On the morning of Jaiwen Hsu’s stem cell transplant in November 2023, the atmosphere in the hospital felt electric. Doctors had never before tried what they were going to attempt with someone like Hsu ...
Researchers at the Cancer Research Institute and the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have ...
Dr. Vinod Balachandran at the Human Oncology & Pathogenesis Program (HOPP) lab. Credit: Memorial Sloan Kettering Cancer Center Pancreatic cancer is notoriously difficult to treat, and about 90% of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results